SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 3.020+3.8%Feb 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (3354)1/1/2013 1:35:41 AM
From: mcbio   of 3570
 
I had pretty much left GERN for dead. But their data with imetelstat against essential thrombocythemia ( ir.geron.com ) has me rethinking. Per recent CC, they have almost 3 years of cash and they believe imetelstat works in diseases with short telomeres (this may include myelofibrosis, which they are expanding testing into).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext